Article Summary Tessa Therapeutics Ltd has announced the close of a US$126 million Series A financing round. The funding was led by Polaris Partners and existing investors, including Temasek, EDBI, Heliconia Capital and Heritas Capital. In conjunction with the financing, Amy Schulman and Darren Carroll, Managing Partners at Polaris Partners, have joined Tessa’s Board of...